Belgium plans to launch a COVID-19 vaccination campaign on a limited scale starting in early January and initially will use
Read more
vaccine
Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nov. 30, 2020– Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a
Read more
AstraZeneca manufacturing error clouds vaccine study results
AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that is raising questions about preliminary results of their experimental
Read more
Restarting global economy depends on tackling ‘last mile’ of vaccine journey
Restarting the global economy for billions of people will depend on successfully overcoming logistical challenges in the ‘last mile’ of
Read more
CDC Warns That COVID-19 Vaccine Might Spur Transient Sickness
TUESDAY, Nov. 24, 2020 — At least three new COVID-19 vaccine candidates are already in the pipeline, with a roll-out
Read more
AstraZeneca’s results signal more good vaccine news—but efficacy is only the beginning of the story
AstraZeneca has become the latest pharmaceutical company to reveal promising results in clinical trials, for its viral vector vaccine developed
Read more
Pfizer will file for emergency FDA approval of covid vaccine TOMORROW
BREAKING NEWS: Pfizer will file for emergency FDA approval of its 95% effective vaccine TOMORROW – but Dr. Fauci warns
Read more
Johnson & Johnson expects coronavirus vaccine to be ready for approval by February, report says
Sen. Portman volunteers for Johnson & Johnson coronavirus vaccine trial Sen. Rob Portman, R-Ohio, calls recent vaccine developments ‘really exciting
Read more
Pfizer to request coronavirus vaccine emergency use authorization ‘within days’
Pfizer completes coronavirus vaccine safety review, will apply for FDA approval GOP Doctors Caucus member Rep. Buddy Carter and New
Read more
Interventions to increase HPV vaccine coverage cost-effective
(HealthDay)—Three interventions for increased human papillomavirus (HPV) vaccine coverage are cost-effective, according to a study published online Nov. 16 in
Read more